KNSA

SEC source: 0001179110-21-007182 · edgar.xml · derivative · entry 1

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,237

Underlying: Class A Common Shares · 33,237 shares

Expires 2031-06-28

F1 · derivative.exercise_date: The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of grant. The date of grant is June 29, 2021.

SEC source: 0001179110-21-007181 · edgar.xml · derivative · entry 1

Cole G Bradley · CIK 0001337798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,237

Underlying: Class A Common Shares · 33,237 shares

Expires 2031-06-28

F1 · derivative.exercise_date: The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of grant. The date of grant is June 29, 2021.

SEC source: 0001638599-21-000595 · doc4_7286.xml · derivative · entry 1

BAKER BROS. ADVISORS LP · CIK 0001263508 · Director

667, L.P. · CIK 0001551139 · Director

Baker Bros. Advisors (GP) LLC · CIK 0001580575 · Director

Baker Brothers Life Sciences LP · CIK 0001363364 · Director

BAKER FELIX · CIK 0001087940 · Director

BAKER JULIAN · CIK 0001087939 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 66,474

Underlying: Class A Common Shares · 66,474 shares

Expires 2031-06-28

F1 · derivative.exercise_price: 33,237 non-qualified share options ("Share Options") exercisable solely into Class A common shares ("Class A Common Shares") of Kiniksa Pharmaceuticals, Ltd. (the "Issuer") each granted to Felix J. Baker, a managing member of Baker Bros. Advisors (GP) LLC (the "Adviser GP") and Dr. Stephen R. Biggar, a full time employee of Baker Bros. Advisors LP (the "Adviser") on June 29, 2021, pursuant to the Issuer's 2018 Incentive Award Plan. The Share Options with a strike price of $14.33 vest in 12 equal monthly installments and expire 10 years from the date of grant. Felix J. Baker and Dr. Biggar serve on the board of directors of the Issuer (the "Board") as representatives of 667, L.P. ("667") and Baker Brothers Life Sciences, L.P. ("Life Sciences", and together with 667, the "Funds").

F1 · derivative.exercise_date: 33,237 non-qualified share options ("Share Options") exercisable solely into Class A common shares ("Class A Common Shares") of Kiniksa Pharmaceuticals, Ltd. (the "Issuer") each granted to Felix J. Baker, a managing member of Baker Bros. Advisors (GP) LLC (the "Adviser GP") and Dr. Stephen R. Biggar, a full time employee of Baker Bros. Advisors LP (the "Adviser") on June 29, 2021, pursuant to the Issuer's 2018 Incentive Award Plan. The Share Options with a strike price of $14.33 vest in 12 equal monthly installments and expire 10 years from the date of grant. Felix J. Baker and Dr. Biggar serve on the board of directors of the Issuer (the "Board") as representatives of 667, L.P. ("667") and Baker Brothers Life Sciences, L.P. ("Life Sciences", and together with 667, the "Funds").

F1 · derivative.expiration_date: 33,237 non-qualified share options ("Share Options") exercisable solely into Class A common shares ("Class A Common Shares") of Kiniksa Pharmaceuticals, Ltd. (the "Issuer") each granted to Felix J. Baker, a managing member of Baker Bros. Advisors (GP) LLC (the "Adviser GP") and Dr. Stephen R. Biggar, a full time employee of Baker Bros. Advisors LP (the "Adviser") on June 29, 2021, pursuant to the Issuer's 2018 Incentive Award Plan. The Share Options with a strike price of $14.33 vest in 12 equal monthly installments and expire 10 years from the date of grant. Felix J. Baker and Dr. Biggar serve on the board of directors of the Issuer (the "Board") as representatives of 667, L.P. ("667") and Baker Brothers Life Sciences, L.P. ("Life Sciences", and together with 667, the "Funds").

F1 · ownership.nature: 33,237 non-qualified share options ("Share Options") exercisable solely into Class A common shares ("Class A Common Shares") of Kiniksa Pharmaceuticals, Ltd. (the "Issuer") each granted to Felix J. Baker, a managing member of Baker Bros. Advisors (GP) LLC (the "Adviser GP") and Dr. Stephen R. Biggar, a full time employee of Baker Bros. Advisors LP (the "Adviser") on June 29, 2021, pursuant to the Issuer's 2018 Incentive Award Plan. The Share Options with a strike price of $14.33 vest in 12 equal monthly installments and expire 10 years from the date of grant. Felix J. Baker and Dr. Biggar serve on the board of directors of the Issuer (the "Board") as representatives of 667, L.P. ("667") and Baker Brothers Life Sciences, L.P. ("Life Sciences", and together with 667, the "Funds").

F2 · ownership.nature: Pursuant to the policies of the Adviser, Felix J. Baker and Dr. Biggar do not have a right to any of the Issuer's securities issued as part of their service on the Board and the Funds are entitled to an indirect proportionate pecuniary interest in the securities. The Funds each own an indirect proportionate pecuniary interest in the Share Options. Solely as a result of their ownership interest in (i) the general partners of the Funds and (ii) the Funds, Felix J. Baker and Julian C. Baker may be deemed to have an indirect pecuniary interest in the Share Options and any Class A Common Shares resulting from the exercise of Share Options (i.e. no direct pecuniary interest).

F3 · ownership.nature: The Adviser serves as the investment adviser to the Funds. In connection with the services provided by the Adviser, the Adviser receives an asset-based management fee that does not confer any pecuniary interest in the securities held by the Funds. The Adviser GP is the Adviser's sole general partner. Julian C. Baker and Felix J. Baker are managing members of the Adviser GP. The Adviser has complete and unlimited discretion and authority with respect to the investment and voting power of the securities held by the Funds. The general partners of the Funds relinquished to the Adviser all discretion and authority with respect to the investment and voting power of the securities held by the Funds. The Adviser has voting and dispositive power over the Share Options and any Class A Common Shares received as a result of the exercise of Share Options.

F4 · ownership.nature: Julian C. Baker, Felix J. Baker, the Adviser GP and the Adviser disclaim beneficial ownership of the securities held directly by the Funds except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that any of Julian C. Baker, Felix J. Baker, the Adviser GP or the Adviser is a beneficial owner of such securities for purposes of Section 16 or any other purpose.

SEC source: 0001179110-21-004651 · edgar.xml · derivative · entry 2

Ragosa Mark · CIK 0001835458 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,962

Underlying: Class A Common Shares · 3,962 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer.

F3 · derivative.exercise_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 26, 2021.

F3 · derivative.expiration_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 26, 2021.

SEC source: 0001179110-21-004651 · edgar.xml · derivative · entry 1

Ragosa Mark · CIK 0001835458 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,725

Underlying: Class A Common Shares · 23,725 shares

Expires 2031-04-25

F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 26, 2021.

SEC source: 0001179110-21-003733 · edgar.xml · derivative · entry 2

Ragosa Mark · CIK 0001835458 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,158

Underlying: Class A Common Shares · 2,158 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

F3 · derivative.exercise_date: The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2023, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.

F3 · derivative.expiration_date: The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2023, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.

SEC source: 0001179110-21-003733 · edgar.xml · derivative · entry 1

Ragosa Mark · CIK 0001835458 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,019

Underlying: Class A Common Shares · 3,019 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

F2 · derivative.exercise_date: The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2022, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.

F2 · derivative.expiration_date: The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2022, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.

SEC source: 0001179110-21-003732 · edgar.xml · derivative · entry 2

Paolini John F. · CIK 0001741533 · SVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,671

Underlying: Class A Common Shares · 3,671 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

F3 · derivative.exercise_date: The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2023, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.

F3 · derivative.expiration_date: The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2023, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.

SEC source: 0001179110-21-003732 · edgar.xml · derivative · entry 1

Paolini John F. · CIK 0001741533 · SVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,676

Underlying: Class A Common Shares · 5,676 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

F2 · derivative.exercise_date: The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2022, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.

F2 · derivative.expiration_date: The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2022, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.

SEC source: 0001179110-21-003730 · edgar.xml · derivative · entry 2

Megna Michael R · CIK 0001464583 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,163

Underlying: Class A Common Shares · 2,163 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

F3 · derivative.exercise_date: The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2023, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.

F3 · derivative.expiration_date: The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2023, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.

SEC source: 0001179110-21-003730 · edgar.xml · derivative · entry 1

Megna Michael R · CIK 0001464583 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,231

Underlying: Class A Common Shares · 3,231 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

F2 · derivative.exercise_date: The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2022, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.

F2 · derivative.expiration_date: The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2022, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.

SEC source: 0001179110-21-003729 · edgar.xml · derivative · entry 2

Patel Sanj K · CIK 0001532218 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,002

Underlying: Class A Common Shares · 12,002 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

F3 · derivative.exercise_date: The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2023, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.

F3 · derivative.expiration_date: The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2023, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.

SEC source: 0001179110-21-003729 · edgar.xml · derivative · entry 1

Patel Sanj K · CIK 0001532218 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,555

Underlying: Class A Common Shares · 18,555 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

F2 · derivative.exercise_date: The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2022, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.

F2 · derivative.expiration_date: The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2022, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.

SEC source: 0001179110-21-003728 · edgar.xml · derivative · entry 2

Beetham Thomas W. · CIK 0001741382 · EVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,287

Underlying: Class A Common Shares · 4,287 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

F3 · derivative.exercise_date: The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2023, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.

F3 · derivative.expiration_date: The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2023, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.

SEC source: 0001179110-21-003728 · edgar.xml · derivative · entry 1

Beetham Thomas W. · CIK 0001741382 · EVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,855

Underlying: Class A Common Shares · 5,855 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

F2 · derivative.exercise_date: The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2022, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.

F2 · derivative.expiration_date: The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2022, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.

SEC source: 0001179110-21-003619 · edgar.xml · derivative · entry 2

Ragosa Mark · CIK 0001835458 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,488

Underlying: Class A Common Shares · 3,488 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer.

F3 · derivative.exercise_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021.

F3 · derivative.expiration_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021.

SEC source: 0001179110-21-003619 · edgar.xml · derivative · entry 1

Ragosa Mark · CIK 0001835458 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,925

Underlying: Class A Common Shares · 20,925 shares

Expires 2031-03-15

F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is March 16, 2021.

SEC source: 0001179110-21-003618 · edgar.xml · derivative · entry 2

Megna Michael R · CIK 0001464583 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,098

Underlying: Class A Common Shares · 3,098 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer.

F3 · derivative.exercise_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021.

F3 · derivative.expiration_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021.

SEC source: 0001179110-21-003618 · edgar.xml · derivative · entry 1

Megna Michael R · CIK 0001464583 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,195

Underlying: Class A Common Shares · 6,195 shares

Expires 2031-03-15

F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is March 16, 2021.

SEC source: 0001179110-21-003617 · edgar.xml · derivative · entry 2

Paolini John F. · CIK 0001741533 · SVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,900

Underlying: Class A Common Shares · 6,900 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer.

F3 · derivative.exercise_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021.

F3 · derivative.expiration_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021.

SEC source: 0001179110-21-003617 · edgar.xml · derivative · entry 1

Paolini John F. · CIK 0001741533 · SVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,400

Underlying: Class A Common Shares · 41,400 shares

Expires 2031-03-15

F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is March 16, 2021.

SEC source: 0001179110-21-003616 · edgar.xml · derivative · entry 2

Patel Sanj K · CIK 0001532218 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,276

Underlying: Class A Common Shares · 26,276 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer.

F3 · derivative.exercise_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021.

F3 · derivative.expiration_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021.

SEC source: 0001179110-21-003616 · edgar.xml · derivative · entry 1

Patel Sanj K · CIK 0001532218 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,658

Underlying: Class A Common Shares · 157,658 shares

Expires 2031-03-15

F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is March 16, 2021.

SEC source: 0001179110-21-003615 · edgar.xml · derivative · entry 2

Beetham Thomas W. · CIK 0001741382 · EVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,769

Underlying: Class A Common Shares · 8,769 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer.

F3 · derivative.exercise_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021.

F3 · derivative.expiration_date: The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021.

SEC source: 0001179110-21-003615 · edgar.xml · derivative · entry 1

Beetham Thomas W. · CIK 0001741382 · EVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,611

Underlying: Class A Common Shares · 52,611 shares

Expires 2031-03-15

F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is March 16, 2021.

SEC source: 0001179110-21-001553 · edgar.xml · derivative · entry 13

Patel Sanj K · CIK 0001532218 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 325,271

Underlying: Class A Common Shares · 1,600 shares

Expires 2025-12-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this From 4 were effected pursuant to a Rule 10b5-1 plan executed by the reporting person on September 3, 2020.

F2 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001179110-21-001553 · edgar.xml · nonDerivative · entry 9

Patel Sanj K · CIK 0001532218 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013

Disclosed balance after: 83,336

F1 · kind: The transactions reported in this From 4 were effected pursuant to a Rule 10b5-1 plan executed by the reporting person on September 3, 2020.

F8 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.15. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

SEC source: 0001179110-21-001553 · edgar.xml · nonDerivative · entry 8

Patel Sanj K · CIK 0001532218 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transactions reported in this From 4 were effected pursuant to a Rule 10b5-1 plan executed by the reporting person on September 3, 2020.

F7 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.18. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

SEC source: 0001179110-21-001553 · edgar.xml · nonDerivative · entry 7

Patel Sanj K · CIK 0001532218 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,600

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this From 4 were effected pursuant to a Rule 10b5-1 plan executed by the reporting person on September 3, 2020.

SEC source: 0001179110-21-001553 · edgar.xml · derivative · entry 12

Patel Sanj K · CIK 0001532218 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 326,871

Underlying: Class A Common Shares · 20,401 shares

Expires 2025-12-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this From 4 were effected pursuant to a Rule 10b5-1 plan executed by the reporting person on September 3, 2020.

F2 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001179110-21-001553 · edgar.xml · nonDerivative · entry 6

Patel Sanj K · CIK 0001532218 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013

Disclosed balance after: 84,473

F1 · kind: The transactions reported in this From 4 were effected pursuant to a Rule 10b5-1 plan executed by the reporting person on September 3, 2020.

F6 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.27. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

SEC source: 0001179110-21-001553 · edgar.xml · nonDerivative · entry 4

Patel Sanj K · CIK 0001532218 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transactions reported in this From 4 were effected pursuant to a Rule 10b5-1 plan executed by the reporting person on September 3, 2020.

F4 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.24. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

SEC source: 0001179110-21-001553 · edgar.xml · nonDerivative · entry 3

Patel Sanj K · CIK 0001532218 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,401

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this From 4 were effected pursuant to a Rule 10b5-1 plan executed by the reporting person on September 3, 2020.

SEC source: 0001179110-21-001553 · edgar.xml · derivative · entry 11

Patel Sanj K · CIK 0001532218 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 347,272

Underlying: Class A Common Shares · 4,924 shares

Expires 2025-12-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this From 4 were effected pursuant to a Rule 10b5-1 plan executed by the reporting person on September 3, 2020.

F2 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001179110-21-001553 · edgar.xml · nonDerivative · entry 5

Patel Sanj K · CIK 0001532218 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013

Disclosed balance after: 108,042

F1 · kind: The transactions reported in this From 4 were effected pursuant to a Rule 10b5-1 plan executed by the reporting person on September 3, 2020.

F5 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.02. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

SEC source: 0001179110-21-001553 · edgar.xml · nonDerivative · entry 2

Patel Sanj K · CIK 0001532218 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transactions reported in this From 4 were effected pursuant to a Rule 10b5-1 plan executed by the reporting person on September 3, 2020.

F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.01. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

SEC source: 0001179110-21-001553 · edgar.xml · nonDerivative · entry 1

Patel Sanj K · CIK 0001532218 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,924

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this From 4 were effected pursuant to a Rule 10b5-1 plan executed by the reporting person on September 3, 2020.

SEC source: 0001179110-21-001370 · edgar.xml · derivative · entry 3

Beetham Thomas W. · CIK 0001741382 · EVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,157

Underlying: Class A Common Shares · 300,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Class B Common Share is convertible at any time at the election of the holder into one Class A Common Share or one Class B1 Common Share and will automatically convert into Class A Common Shares upon transfer to an unaffiliated party.

F1 · derivative.exercise_date: Each Class B Common Share is convertible at any time at the election of the holder into one Class A Common Share or one Class B1 Common Share and will automatically convert into Class A Common Shares upon transfer to an unaffiliated party.

F1 · derivative.expiration_date: Each Class B Common Share is convertible at any time at the election of the holder into one Class A Common Share or one Class B1 Common Share and will automatically convert into Class A Common Shares upon transfer to an unaffiliated party.

SEC source: 0001179110-21-001370 · edgar.xml · nonDerivative · entry 2

Beetham Thomas W. · CIK 0001741382 · EVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 297,523

F2 · kind: The transactions reported in this From 4 were effected pursuant to a Rule 10b5-1 plan executed by the reporting person on June 19, 2020.

F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $22.05 to $22.18. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

SEC source: 0001179110-21-001370 · edgar.xml · nonDerivative · entry 1

Beetham Thomas W. · CIK 0001741382 · EVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Class B Common Share is convertible at any time at the election of the holder into one Class A Common Share or one Class B1 Common Share and will automatically convert into Class A Common Shares upon transfer to an unaffiliated party.

SEC source: 0001179110-21-000198 · edgar.xml · derivative · entry 3

Ragosa Mark · CIK 0001835458 · Interim CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Share · 4,404 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer.

F2 · derivative.exercise_date: The RSU will vest in a single installment on December 31, 2020, subject to the Reporting Person's continuous employment or service to the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSU.

F2 · derivative.expiration_date: The RSU will vest in a single installment on December 31, 2020, subject to the Reporting Person's continuous employment or service to the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSU.

SEC source: 0001179110-21-000198 · edgar.xml · nonDerivative · entry 2

Ragosa Mark · CIK 0001835458 · Interim CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,107

SEC source: 0001179110-21-000198 · edgar.xml · nonDerivative · entry 1

Ragosa Mark · CIK 0001835458 · Interim CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,404

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer.

SEC source: 0001179110-21-000197 · edgar.xml · derivative · entry 3

Rizvi Qasim · CIK 0001794636 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Share · 7,337 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer.

F2 · derivative.exercise_date: The RSU will vest in a single installment on December 31, 2020, subject to the Reporting Person's continuous employment or service to the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSU.

F2 · derivative.expiration_date: The RSU will vest in a single installment on December 31, 2020, subject to the Reporting Person's continuous employment or service to the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSU.

SEC source: 0001179110-21-000197 · edgar.xml · nonDerivative · entry 2

Rizvi Qasim · CIK 0001794636 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,176

SEC source: 0001179110-21-000197 · edgar.xml · nonDerivative · entry 1

Rizvi Qasim · CIK 0001794636 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,337

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer.

SEC source: 0001179110-22-002329 · edgar.xml · nonDerivative · entry 2

Megna Michael R · CIK 0001464583 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,183

F2 · kind: The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of July 1, 2020 to December 31, 2020. The acquisition of such shares was exempt pursuant to Rule 16b-3(c).

SEC source: 0001179110-20-010450 · edgar.xml · derivative · entry 9

Patel Sanj K · CIK 0001532218 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 352,196

Underlying: Class A Common Shares · 150,700 shares

Expires 2025-12-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sale of Class A Common Shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan executed by the reporting person.

F4 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001179110-20-010450 · edgar.xml · nonDerivative · entry 6

Patel Sanj K · CIK 0001532218 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013

Disclosed balance after: 112,570

F1 · kind: The sale of Class A Common Shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan executed by the reporting person.

F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $21.00 to $21.08. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

SEC source: 0001179110-20-010450 · edgar.xml · nonDerivative · entry 5

Patel Sanj K · CIK 0001532218 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sale of Class A Common Shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan executed by the reporting person.

F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $21.00 to $21.08. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.